158 related articles for article (PubMed ID: 35754823)
1. Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes.
Hanson AL; Sahhar J; Ngian GS; Roddy J; Walker J; Stevens W; Nikpour M; Assassi S; Proudman S; Mayes MD; Kenna TJ; Brown MA
Front Genet; 2022; 13():913196. PubMed ID: 35754823
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes.
Acosta-Herrera M; Kerick M; Lopéz-Isac E; Assassi S; Beretta L; Simeón-Aznar CP; Ortego-Centeno N; ; Proudman SM; ; Hunzelmann N; Moroncini G; de Vries-Bouwstra JK; Orozco G; Barton A; Herrick AL; Terao C; Allanore Y; Brown MA; Radstake TR; Fonseca C; Denton CP; Mayes MD; Martin J
Ann Rheum Dis; 2021 Aug; 80(8):1040-1047. PubMed ID: 34096881
[TBL] [Abstract][Full Text] [Related]
3. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis in mother and daughter with susceptible HLA haplotype and anti-topoisomerase I autoantibodies.
Kurteva EK; Boyadzhieva VV; Stoilov NR
Rheumatol Int; 2020 Jun; 40(6):1001-1009. PubMed ID: 31970496
[TBL] [Abstract][Full Text] [Related]
5. Epistatic interactions between killer immunoglobulin-like receptors and human leukocyte antigen ligands are associated with ankylosing spondylitis.
Hanson AL; ; Vukcevic D; Leslie S; Harris J; Lê Cao KA; Kenna TJ; Brown MA
PLoS Genet; 2020 Aug; 16(8):e1008906. PubMed ID: 32804949
[TBL] [Abstract][Full Text] [Related]
6. The investigation of killer cell immunoglobulin-like receptor genotyping in patients with systemic lupus erytematosus and systemic sclerosis.
Tozkır JD; Tozkır H; Gürkan H; Dönmez S; Eker D; Pamuk GE; Pamuk ÖN
Clin Rheumatol; 2016 Apr; 35(4):919-25. PubMed ID: 26960450
[TBL] [Abstract][Full Text] [Related]
7.
Machado-Sulbaran AC; Ramírez-Dueñas MG; Navarro-Zarza JE; Muñoz-Valle JF; Mendoza-Carrera F; Baños-Hernández CJ; Parra-Rojas I; Montoya-Buelna M; Sánchez-Hernández PE
J Immunol Res; 2019; 2019():6808061. PubMed ID: 30723749
[TBL] [Abstract][Full Text] [Related]
8. Identifying the immune interactions underlying HLA class I disease associations.
Debebe BJ; Boelen L; Lee JC; ; Thio CL; Astemborski J; Kirk G; Khakoo SI; Donfield SM; Goedert JJ; Asquith B
Elife; 2020 Apr; 9():. PubMed ID: 32238263
[TBL] [Abstract][Full Text] [Related]
9. Association of HLA class II genes with systemic sclerosis in Koreans.
Kang SH; Park MH; Song EY; Kang SJ; Lee EB; Song YW; Takeuchi F
J Rheumatol; 2001 Jul; 28(7):1577-83. PubMed ID: 11469465
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.
Gorlova O; Martin JE; Rueda B; Koeleman BP; Ying J; Teruel M; Diaz-Gallo LM; Broen JC; Vonk MC; Simeon CP; Alizadeh BZ; Coenen MJ; Voskuyl AE; Schuerwegh AJ; van Riel PL; Vanthuyne M; van 't Slot R; Italiaander A; Ophoff RA; Hunzelmann N; Fonollosa V; Ortego-Centeno N; González-Gay MA; García-Hernández FJ; González-Escribano MF; Airo P; van Laar J; Worthington J; Hesselstrand R; Smith V; de Keyser F; Houssiau F; Chee MM; Madhok R; Shiels PG; Westhovens R; Kreuter A; de Baere E; Witte T; Padyukov L; Nordin A; Scorza R; Lunardi C; Lie BA; Hoffmann-Vold AM; Palm O; García de la Peña P; Carreira P; ; Varga J; Hinchcliff M; Lee AT; Gourh P; Amos CI; Wigley FM; Hummers LK; Nelson JL; Riemekasten G; Herrick A; Beretta L; Fonseca C; Denton CP; Gregersen PK; Agarwal S; Assassi S; Tan FK; Arnett FC; Radstake TR; Mayes MD; Martin J
PLoS Genet; 2011 Jul; 7(7):e1002178. PubMed ID: 21779181
[TBL] [Abstract][Full Text] [Related]
11. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
[TBL] [Abstract][Full Text] [Related]
12. Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis.
Kuwana M; Inoko H; Kameda H; Nojima T; Sato S; Nakamura K; Ogasawara T; Hirakata M; Ohosone Y; Kaburaki J; Okano Y; Mimori T
Intern Med; 1999 Apr; 38(4):336-44. PubMed ID: 10361906
[TBL] [Abstract][Full Text] [Related]
13. HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients.
Fanning GC; Welsh KI; Bunn C; Du Bois R; Black CM
Br J Rheumatol; 1998 Feb; 37(2):201-7. PubMed ID: 9569077
[TBL] [Abstract][Full Text] [Related]
14. Association of killer cell immunoglobulin-like receptor and human leucocyte antigen-Cw gene combinations with systemic lupus erythematosus.
Hou Y; Zhang C; Xu D; Sun H
Clin Exp Immunol; 2015 May; 180(2):250-4. PubMed ID: 25581336
[TBL] [Abstract][Full Text] [Related]
15. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis.
Beretta L; Rueda B; Marchini M; Santaniello A; Simeón CP; Fonollosa V; Caronni M; Rios-Fernandez R; Carreira P; Rodriguez-Rodriguez L; ; Moreno A; López-Nevot MA; Escalera A; González-Escribano MF; Martin J; Scorza R
Rheumatology (Oxford); 2012 Jan; 51(1):52-9. PubMed ID: 22087014
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the HLA-DRβ1 third hypervariable region amino acid sequence according to charge and parental inheritance in systemic sclerosis.
Gentil CA; Gammill HS; Luu CT; Mayes MD; Furst DE; Nelson JL
Arthritis Res Ther; 2017 Mar; 19(1):46. PubMed ID: 28270189
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
[TBL] [Abstract][Full Text] [Related]
19. KIR-HLA profiling shows presence of higher frequencies of strong inhibitory KIR-ligands among prognostically poor risk AML patients.
Shen M; Linn YC; Ren EC
Immunogenetics; 2016 Feb; 68(2):133-44. PubMed ID: 26649563
[TBL] [Abstract][Full Text] [Related]
20. The immunogenetics of multiple sclerosis: A comprehensive review.
Hollenbach JA; Oksenberg JR
J Autoimmun; 2015 Nov; 64():13-25. PubMed ID: 26142251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
